All Comments by Brigita Urbanc

  1. Soluble Oligomer Assay Rivals Other Biomarkers in Detecting Preclinical AD
  2. Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide.
  3. Amyloid Deposits Not Always Toxic to Cells
  4. Electron Microscope Yields Finer Structure of α-Synuclein, Aβ Fibrils
  5. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
  6. Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to β-sheet in amyloid fibril formation.
  7. The Toxic Fold? Aβ Dodecamers, Tetramers Show Their Conformations
  8. Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure.
  9. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
  10. Low-power laser irradiation inhibiting Abeta25-35-induced PC12 cell apoptosis via PKC activation.
  11. Affibodies—Putting the β in Aβ?
  12. Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity.
  13. Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils.
  14. Linking folding with aggregation in Alzheimer's beta-amyloid peptides.
  15. Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus.